10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,213,000 | -49.1% | 68,885 | -1.5% | 0.02% | -44.4% |
| Q4 2021 | $10,246,000 | +0.9% | 69,921 | +0.3% | 0.04% | -7.7% |
| Q3 2021 | $10,151,000 | -26.6% | 69,689 | -0.6% | 0.04% | -23.5% |
| Q2 2021 | $13,835,000 | +18.3% | 70,100 | +6.2% | 0.05% | +10.9% |
| Q1 2021 | $11,694,000 | +26.0% | 66,011 | +1.2% | 0.05% | +21.1% |
| Q4 2020 | $9,284,000 | +114.8% | 65,231 | +88.2% | 0.04% | +90.0% |
| Q3 2020 | $4,322,000 | – | 34,667 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |